Intraocular Lens (IOL) Market Research Report Of Medical Devices Pipeline Assessment, 2017

“The Latest Research Report Intraocular Lens (IOL) – Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Intraocular Lens (IOL) Market

GlobalData’s Medical Devices sector report, Intraocular Lens (IOL) – Medical Devices Pipeline Assessment, 2017″ provides an overview of Intraocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intraocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1342840

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Intraocular Lens (IOL) under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Intraocular Lens (IOL) under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the products current stage of development, territory and estimated launch date

View Sample PDF @ https://www.marketresearchreports.biz/reports/1342840/intraocular-lens-iol-medical-devices-pipeline-assessment-2017-market-research-reports.pdf

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 13

2 Introduction 14

2.1 Intraocular Lens (IOL) Overview 14

3 Products under Development 15

3.1 Intraocular Lens (IOL) – Pipeline Products by Stage of Development 15

3.2 Intraocular Lens (IOL) – Pipeline Products by Segment 16

3.3 Intraocular Lens (IOL) – Pipeline Products by Territory 17

3.4 Intraocular Lens (IOL) – Pipeline Products by Regulatory Path 18

3.5 Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date 19

3.6 Intraocular Lens (IOL) – Ongoing Clinical Trials 20

4 Intraocular Lens (IOL) – Pipeline Products under Development by Companies 21

4.1 Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development 21

4.2 Intraocular Lens (IOL) – Pipeline Products by Stage of Development 23

5 Intraocular Lens (IOL) Companies and Product Overview 28

5.1 Abbott Medical Optics Inc Company Overview 28

5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.2 Adoptics AG (Inactive) Company Overview 30

5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 AkkoLens International BV Company Overview 31

5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 31

5.4 Alcon Laboratories Inc Company Overview 32

5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.5 Anew Optics, Inc. Company Overview 41

5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

5.6 Bausch & Lomb Inc Company Overview 42

5.6.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.7 Clarvista Medical, Inc. Company Overview 43

5.7.1 Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.8 Elenza, Inc. Company Overview 47

5.8.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.9 Emmetrope Incorporated Company Overview 48

5.9.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 48

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1342840

5.10 Eye4Vision Ophthalmics International Company Overview 51

5.10.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 51

5.11 EyeKon Medical Inc Company Overview 52

5.11.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.12 Hoya Surgical Optics Inc Company Overview 108

5.12.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.13 IFS Construction Services Ltd Company Overview 110

5.13.1 IFS Construction Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.14 InfiniteVision Optics, SAS Company Overview 111

5.14.1 InfiniteVision Optics, SAS Pipeline Products & Ongoing Clinical Trials Overview 111

5.15 Innovia LLC Company Overview 114

5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 114

5.16 LayerBio Inc Company Overview 115

5.16.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.17 LensGen, Inc. Company Overview 116

5.17.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116

5.18 London Eye Hospital Pharma Company Overview 117

5.18.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview 117

5.19 Meir Medical Center Company Overview 118

5.19.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118

5.20 Morcher Gmbh Company Overview 119

5.20.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 119

5.21 NuLens Ltd. (Inactive) Company Overview 141

5.21.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141

5.22 Ocumetics Technology Corp Company Overview 142

5.22.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 142

5.23 PowerVision, Inc. Company Overview 143

5.23.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143

5.24 Presbeasy Company Overview 146

5.24.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 146

5.25 Rayner Intraocular Lenses Ltd Company Overview 147

5.25.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 147

5.26 RxSight Inc Company Overview 162

5.26.1 RxSight Inc Pipeline Products & Ongoing Clinical Trials Overview 162

5.27 Santen Pharmaceutical Co Ltd Company Overview 163

5.27.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

5.28 Sharklet Technologies, Inc. Company Overview 164

5.28.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164

5.29 STAAR Surgical Company Company Overview 165

5.29.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 165

5.30 Strathspey Crown LLC Company Overview 170

5.30.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 170

5.31 University of Rochester Company Overview 171

5.31.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 171

5.32 University of Tampere Company Overview 172

5.32.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 172

5.33 Valeant Pharmaceuticals International Inc Company Overview 173

5.33.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.34 Visidome Ltd Company Overview 174

5.34.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.35 Visioneering Technologies Inc Company Overview 175

5.35.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 175

5.36 Washington University in St Louis Company Overview 176

5.36.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 176

5.37 Xend Company Overview 177

5.37.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 177

5.38 Z Lens LLC Company Overview 178

5.38.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 178

6 Intraocular Lens (IOL)- Recent Developments 179

6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 179

6.2 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, LUCIDIS 179

6.3 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, EDEN 180

6.4 Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts 180

6.5 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 180

6.6 Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs 181

6.7 Aug 15, 2017: World’s fastest growing IOL Company – Opens Second Manufacturing Facility in Thailand 182

6.8 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 182

6.9 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results 185

6.10 Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island 186

6.11 Jul 27, 2017: Hoya Reports First Quarter Financial Results 187

6.12 Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina 187

6.13 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 188

6.14 Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno 190

6.15 Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey 190

6.16 Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco 191

6.17 Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego 191

6.18 Jun 27, 2017: Visioneering Technologies Names Mark Rapoport as New CFO 192

6.19 Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 192

6.20 Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 193

Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1342840&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Leave a Reply